Performance differences seen in continuous glucose monitors

January 25, 2013
Performance differences seen in continuous glucose monitors
Continuous glucose monitoring devices vary in performance characteristics, according to a comparative effectiveness study published online Dec. 28 in Diabetes Care.

(HealthDay)—Continuous glucose monitoring (CGM) devices vary in performance characteristics, according to a comparative effectiveness study published online Dec. 28 in Diabetes Care.

Edward R. Damiano, Ph.D., from Boston University, and colleagues recruited six patients with (age 52 ± 14 years) to participate in two 51-hour closed-loop blood glucose control experiments. Subjects simultaneously wore three CGM devices—the Navigator (Abbott ), the Seven Plus (DexCom), and the Guardian ()—to obtain CGM glucose (CGMG) measurements. Measurements were paired with corresponding venous (PG) measurements (GlucoScout, International Biomedical) obtained every 15 min (2,360 values).

The researchers found that the Navigator had the best overall accuracy, with an aggregate mean absolute relative difference (MARD) of all paired points (PG-CGMG measurements) of 11.8 ± 11.1 percent and an average MARD across all 12 experiments of 11.8 ± 3.8 percent. The Seven Plus had an aggregate MARD of all paired points of 16.5 ± 17.8 percent and an average MARD across all 12 experiments of 16.5 ± 6.7 percent. For the Guardian, the corresponding figures were 20.3 ± 18.0 percent and 20.2 ± 6.8 percent. Reliability, as measured by data reporting percentages, was 76 percent for the Seven Plus and close to 100 percent for the Navigator and Guardian.

"The results of this head-to-head-to-head study reveal the Navigator was the most accurate and precise of the current generation of CGM devices, followed by the Seven Plus and the Guardian," the authors write.

International Biomedical provided GlucoScout monitors and technical assistance regarding their use.

Explore further: Experts find continuous glucose monitoring beneficial in maintaining target blood glucose levels

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Experts find continuous glucose monitoring beneficial in maintaining target blood glucose levels

October 11, 2011
Patients with diabetes face daily challenges in managing their blood glucose levels, and it has been postulated that patients could benefit from a system providing continuous real-time glucose readings. Today, The Endocrine ...

ADA: Hypo-hyperglycemia minimizer system feasible

June 12, 2012
(HealthDay) -- The hypoglycemia-hyperglycemia minimizer (HHM) system, which includes a continuous, subcutaneous insulin infusion pump, continuous glucose monitor (CGM), and software, is able to predict changes in blood glucose ...

Fasting plasma glucose beats HbA1c for diabetes screening

January 17, 2013
(HealthDay)—For patients without diabetes undergoing coronary angiography (CAG), fasting plasma glucose (FPG) performs better in diabetes screening than glycated hemoglobin (HbA1c), according to a study published online ...

Study assesses glucose monitoring trends in tweens

April 12, 2012
(HealthDay) -- During the transition to adolescence, children with type 1 diabetes monitor their blood glucose less frequently, resulting in significant increases in HbA1c levels, according to research published online April ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.